Bill

Bill > H1130


MA H1130

Relative to studying the benefits of single tablet regimen


summary

Introduced
01/23/2017
In Committee
01/23/2017
Crossed Over
Passed
Dead
12/31/2018

Introduced Session

190th General Court

Bill Summary

Relative to conducting a study regarding the benefits and costs of single tablet regimens or long acting alternative regimens for the treatment of HIV. Public Health.

AI Summary

This bill requires the Department of Public Health to conduct a study on the effectiveness, costs, and benefits of single-tablet regimens or long-acting alternative regimens, such as patches, sub-cutaneous, implantable, or intramuscular treatments, compared to multi-tablet regimens used to treat HIV. The study will analyze whether these regimens are clinically equal, which might be more effective and more likely to result in adherence, how improved adherence may increase viral suppression and decrease HIV transmission, any cost savings from avoided lifetime medical costs of prevented HIV infections, and how they might improve the quality of life related to pill burden for patients. The Department must report its findings and recommendations for legislative or regulatory improvements by December 31, 2018.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Accompanied a study order, see H4625 (on 06/18/2018)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...